Insecticidal compound based on plant source beta-asarone and application thereof

By developing insecticide compounds based on plant-source β-asarone, the problems of insufficient pest resistance and plant-source insecticide activity of chemical insecticides are solved, and efficient insecticides are achieved for hemipteran pests, which is safe and environmentally friendly. Suitable for large-scale production.

CN119039121APending Publication Date: 2024-11-29SHANDONG ACADEMY OF AGRICULTURAL SCIENCES
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411160388.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-22
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

The excessive use of chemical insecticides leads to the development of pest resistance, affecting crop production safety. The existing plant-source insecticides have insufficient insecticide activities and are difficult to replace traditional insecticides.

Method used

An insecticidal compound based on plant-source β-asarone and its pharmaceutical salts were developed to prepare insecticidal agents or drugs for field pests by synthesizing compounds such as (2,4,5-trimethoxyphenyl)methanol and its derivatives. , especially for hemiptera pests, it has excellent insecticidal activity.

Benefits of technology

The insecticidal activity of compounds on hemipteran pests is significantly improved, especially for ash planthoppers, peanut aphids, corn aphids, whiteflies and cinnabar spider mites. It is safer and pollution-free due to the use of plant-source materials. Simple process and easy to produce on a large scale.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119039121A_ABST
    Figure CN119039121A_ABST
Patent Text Reader

Abstract

The invention provides an insecticidal compound based on plant source beta-asarone and application of the insecticidal compound, a general formula of the insecticidal compound is shown as a formula (I), the insecticidal compound based on the plant source beta-asarone is designed and synthesized, the insecticidal compound is novel in structure, and the insecticidal compound has excellent insecticidal activity on hemiptera pests. The compound disclosed by the invention is ingenious in design, simple in structure, cheap and easily available in raw materials, simple, convenient, safe and environment-friendly in synthesis process and easy for large-scale production. # imgabs0 #
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of insecticides, and in particular relates to an insecticidal compound based on plant-derived β-asarone and application thereof. Background Art

[0002] In agricultural ecosystems, chemical pesticides are still the fastest and most effective means of responding to pest outbreaks and one of the most important ways to protect plants. However, with the changes in natural conditions and farming systems such as global climate change, crop farming methods, and cross-regional mechanized operations, the use of chemical pesticides is also increasing day by day, especially the large-scale use of single agents or chemical agents with similar mechanisms of action, which ultimately leads to the emergence of pest resistance and the resurgence of pests, seriously affecting the production safety of crops.

[0003] Botanical insecticides mainly include active ingredients extracted from plants and compounds and derivatives synthesized based on active structures. They are becoming more and more popular because of their safety and pollution-free characteristics. However, there is a large gap between the insecticidal activity of botanical compounds and chemical insecticides. Therefore, improving the insecticidal activity of botanical compounds is a prerequisite for their widespread application. Summary of the invention

[0004] Purpose of the invention: In view of the deficiencies in the prior art, the present invention provides an insecticidal compound based on plant-derived β-asarone, which has very excellent insecticidal activity against field pests, especially Hemiptera pests.

[0005] The present invention also provides the application of the plant-derived β-asarone-based insecticidal compound.

[0006] Technical solution: In order to achieve the above-mentioned purpose, the present invention provides an insecticidal compound based on plant-derived β-asarone and a pharmaceutically acceptable salt thereof, wherein the general formula of the insecticidal compound is shown in formula (I):

[0007]

[0008] Wherein R1 is selected from any of the following: C 1-4 Alkyl, C 1-4 Haloalkyl, C 3-8 Cycloalkyl, C 3-8 Halogenated cycloalkyl, -CH2OH, -CH2OTMS, halogen, -CHO, -COOR2, -CONHR3;

[0009] The R2 is selected from any one of the following: H,

[0010] The R3 is selected from any one of the following:

[0011] Wherein, the insecticidal compound based on plant-derived β-asarone and its pharmaceutically acceptable salt, the general formula of the insecticidal compound is as shown in formula (I):

[0012] Wherein R1 is selected from any one of the following: -CHCHCH3(E), -CHCHCH3(Z), CH2OH, -CH2OTMS, Br, -CHO, -CHCBr2, -COOR2, -CONHR3;

[0014] The R2 is selected from any one of the following: H,

[0015] The R3 is selected from any one of the following:

[0016] The insecticidal compound based on plant-derived β-asarone and its pharmaceutically acceptable salt according to the present invention is selected from any one of the compounds in Table 1 below:

[0017] Table 1

[0018]

[0019]

[0020] Use of the compound of the present invention or its pharmaceutically acceptable salt in the preparation of insecticides or medicines.

[0021] Wherein, the compound or a pharmaceutically acceptable salt thereof is used in the preparation of an insecticide or medicine for field pests.

[0022] Wherein, the field pests include Hemiptera pests.

[0023] Furthermore, the field pests include Laodelphax striatum, Carrot aphid, Peanut aphid, Corn aphid, Bemisia tabaci and Tetranychus cinnabarinus.

[0024] The insecticide composition of the present invention comprises any one of the above compounds or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier or diluent.

[0025] Wherein, the pharmaceutical composition is selected from emulsifiable concentrate, aqueous emulsion, suspension or wettable powder.

[0026] The insecticide composition of the present invention is used in the preparation of insecticide reagents or medicines.

[0027] Preferably, the method for preparing the compound of the present invention comprises the following steps:

[0028]

[0029] Beneficial effects: Compared with the prior art, the present invention has the following advantages:

[0030] (1) The present invention designs and synthesizes novel insecticidal compounds based on plant-derived β-asarone, which have excellent insecticidal activity against Hemiptera pests.

[0031] (2) Compared with compound (1), the insecticidal activity of compounds (7)(8)(9)(10)(20) against gray leafhopper was increased by 4.56-8.31 times, among which compound (10) had the best insecticidal effect against gray leafhopper, increasing by 8.31 times.

[0032] (3) The compounds of the present invention also have excellent insecticidal activity against Hemiptera pests such as peanut aphid, corn aphid, carrot microtubule aphid, Bemisia tabaci and Tetranychus cinnabarinus of the family Tetranychus.

[0033] (4) The present invention uses botanical insecticide compounds, which are mainly active ingredients extracted from plants and compounds and derivatives synthesized based on active structures. Compared with traditional compounds, they are safer and pollution-free.

[0034] (5) The compounds of the present invention are ingeniously designed, simple in structure, and made from cheap and readily available raw materials. The synthetic process is simple, safe, and environmentally friendly, and is easy to mass produce. BRIEF DESCRIPTION OF THE DRAWINGS

[0035] Figure 1 is the hydrogen spectrum of compound 9;

[0036] Figure 2 is the carbon spectrum of compound 9;

[0037] Figure 3 is the hydrogen spectrum of compound 10;

[0038] Figure 4 is the carbon spectrum of compound 10;

[0039] Figure 5 is the hydrogen spectrum of compound 11;

[0040] Figure 6 is the carbon spectrum of compound 11;

[0041] Figure 7 is the fluorine spectrum of compound 11;

[0042] Figure 8 is the hydrogen spectrum of compound 12;

[0043] Fig. 9 is the carbon spectrum of compound 12;

[0044] Fig.10 is the fluorine spectrum of compound 12;

[0045] Fig.11 is the hydrogen spectrum of compound 13;

[0046] Fig.12 is the carbon spectrum of compound 13;

[0047] Fig.13 is the hydrogen spectrum of compound 14;

[0048] Fig.14 is the carbon spectrum of compound 14;

[0049] Fig.15 is the hydrogen spectrum of compound 15;

[0050] Fig.16 is the carbon spectrum of compound 15;

[0051] Fig.17 is the fluorine spectrum of compound 15;

[0052] Fig.18 is the hydrogen spectrum of compound 16;

[0053] Fig.19 is the carbon spectrum of compound 16;

[0054] Fig. 20 is the hydrogen spectrum of compound 17;

[0055] Fig.21 is the carbon spectrum of compound 17;

[0056] Fig. 22 is the hydrogen spectrum of compound 18;

[0057] Fig.23 is the carbon spectrum of compound 18;

[0058] Fig.24 is the hydrogen spectrum of compound 19;

[0059] Fig.25 is the carbon spectrum of compound 19;

[0060] Fig.26 is the hydrogen spectrum of compound 20;

[0061] Fig. 27 is the carbon spectrum of compound 20. DETAILED DESCRIPTION

[0062] The present invention is further described below in conjunction with specific embodiments, but the present invention is not limited to these specific embodiments. Those skilled in the art should recognize that the present invention covers all possible alternatives, improvements and equivalents within the scope of the claims.

[0063] The experimental methods described in the examples are conventional methods unless otherwise specified; the materials, reagents, etc. used in the examples are all commercially available unless otherwise specified.

[0064] Compounds 1-8 in the present invention are known compounds, and their names and CAS numbers are as follows:

[0065] Compound 1: (Z)-1,2,4-trimethoxy-5-(prop-1-en-1-yl)benzene(β-Asarone), cas: 5273-86-9.

[0066] Compound 2: (E)-1,2,4-trimethoxy-5-(prop-1-en-1-yl)benzene(α-Asaron), cas: 2883-98-9.

[0067] Compound 3: 2,4,5-trimethoxybenzaldehyde, cas: 4460-86-0.

[0068] Compound 4: (E)-1-methoxy-4-(prop-1-en-1-yl)benzene(cis-Anethol), cas: 104-46-1.

[0069] Compound 5: 4-allyl-2-methoxyphenol (Eugenol), cas: 97-53-0.

[0070] Compound 6: (E)-2-methoxy-4-(prop-1-en-1-yl)phenol(Isoeugenol), cas: 97-54-1.

[0071] Compound 7: 2,4,5-Trimethoxybenzoic acid, cas: 490-64-2.

[0072] Compound 8: (E)-4-(3,5-dimethoxystyryl)phenol(Pterostilbene), cas: 537-42-8.

[0073] Compounds 9-20 in the present invention are synthesized by various embodiments of the present invention. The hydrogen spectrum, carbon spectrum or fluorine spectrum of the synthesized compounds are respectively as follows: Figure 1-Figure 27 shown.

[0074] Example 1

[0075] Preparation of (2,4,5-trimethoxyphenyl)methanol (Compound 9):

[0076]

[0077] Compound 3 (12.5 g, 12.7 mmol) was dissolved in MeOH (30 mL), cooled to 0 ° C, and a solution of sodium borohydride (0.63 g, 16.5 mmol) in MeOH (20 mL) was added dropwise. The reaction mixture was slowly heated to room temperature and stirred for 12 hours, and 1M HCl (30 mL) was slowly added to destroy the excess borohydride. The aqueous phase was extracted with ethyl acetate (3 × 50 mL). The combined organic phase was washed with saturated NaHCO3 aqueous solution (100 mL) and brine (150 mL) in turn, and dried over anhydrous Na2SO4. The solvent was then removed under reduced pressure, and the residue was purified by silica gel column chromatography (ethyl acetate / petroleum ether=1:10) to obtain white solid compound 9 (2.0 g, 80% yield), melting point 62.5-63.5 ° C. 1HNMR(500MHz,Chloroform-d)δ6.83(s,1H),6.49(s,1H),4.58(d,J=6.2Hz,2H),3.85(s,3H),3.80(d,J=1.6Hz,6H),2.44(t,J=6.3Hz,1H).13C NMR(126MHz, CDCl3)δ151.62,149.13,142.85,120.67,113.18,97.35,61.25,56.59,56.24,56.15.HRMS(ESI)calcd for C10H13O3[M-OH]+181.0859,found 181.0868.

[0078] Example 2

[0079] Preparation of 6-chloropyridin-3-yl 2,4,5-trimethoxybenzoate (Compound 10):

[0080]

[0081] At room temperature and under argon protection, compound 7 (0.21 g, 1.0 mmol), EDCl·HCl (0.21 g, 1.1 mmol) and HOBt (0.14 g, 1.0 mmol) were added to anhydrous CH3CN (8 mL), stirred and mixed, and a solution of 6-chloropyridin-3-ol (0.13 g, 1.0 mmol) in anhydrous CH3CN (3 mL) was added dropwise. The reaction mixture was stirred for 24 hours and quenched with H2O (8 mL). The aqueous phase was extracted with ethyl acetate (3×30 mL), and the combined organic phases were washed with brine (50 mL), dried over anhydrous Na2SO4, and then the solvent was removed under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate / petroleum ether=1:2) to obtain a white solid compound 10 (0.23 g, 70%), with a melting point of 139.3-140.0°C. 1H NMR(500MHz,Chloroform-d)δ8.31(d,J=2.8Hz,1H),7.58(dd,J=8.6,2.9Hz,1H),7.55 (s,1H),7.37(d,J=8.6Hz,1H),6.57(s,1H),3.98(s,3H),3.94(s,3H),3.91(s,3H).13C NMR (126MHz, CDCl3) δ162.96,157.35,155.19,147.62,147.00,143.51,142.82,132.84,124.63,114.70, 108.09,97.42,56.99,56.68,56.29.HRMS(ESI)calcdforC15H15ClNO5[M+H]+324.0633,found324.0646.

[0082] Example 3

[0083] Preparation of (6-(trifluoromethyl)pyridin-3-yl)methyl 2,4,5-trimethoxybenzoate (Compound 11):

[0084]

[0085] Referring to the synthesis method of Example 2, compound 7 (0.21 g, 1.0 mmol) was subjected to esterification reaction with (6-(trifluoromethyl)pyridin-3-yl)methanol (0.16 g, 1.0 mmol) to synthesize white solid compound 11 (0.27 g, 73% yield), melting point 102.3-102.5°C. 1H NMR (500 MHz, Chloroform-d) δ8.85 (s, 1H), 8.00–7.95 (m, 1H), 7.72–7.69 (m, 1H), 7.43 (s, 1H), 6.54 (s, 1H), 5.43 (s, 2H), 3.95 (s, 3H), 3.92 (s, 3H), 3.87 (s, 3H).13C NMR (126MHz, CDCl3) δ165.35,156.31,154.38,149.53,148.61,142.80,136.90,135.75,CF3(12 5.99,117.44,109.29,104.10),120.42,114.63,109.53,97.51,63.14,57.01,56.65,56.24.19F NMR(471MHz, CDCl3)δ-67.89.HRMS(ESI)calcd forC17H17F3NO5[M+H]+372.1053, found 372.1069.

[0086] Example 4

[0087] Preparation of 3-(trifluoromethyl)phenyl 2,4,5-trimethoxybenzoate (Compound 12):

[0088]

[0089] Referring to the synthesis method of Example 2, compound 7 (0.21 g, 1.0 mmol) and 3-(trifluoromethyl)phenol (0.18 g, 1.0 mmol) were subjected to esterification reaction to synthesize white solid compound 12 (0.24 g, 68% yield). Melting point 143.4-143.6°C. 1 HNMR(500MHz,Chloroform-d)δ7.58(s,1H),7.55–7.48(m,3H),7.44–7.37(m,1H),6.58(s,1H),3.98(s,3H),3.95(s,3H),3.91(s,3H). 13C NMR(126MHz, CDCl3)δ163.40,157.16,154.88,151.31,142.82,(132.37,132.11,131.85,131.59),129.98,127.03,CF3(124.86,122.70 ,125.82,120.53),(122.54,122.51,122.48,122.45),(119.56,119.53,119.50,119.47),114.73,108.85,97.63,57.10,56.64,56.26. 19 F NMR(471MHz,CDCl3)δ-62.62.HRMS(ESI)calcd for C 17 H 16 F3O5[M+H] + 357.0944, found 357.0960.

[0090] Example 5

[0091] Preparation of 5-chloro-N,3-dimethyl-2-(2,4,5-trimethoxybenzamido)benzamide (Compound 13):

[0092]

[0093] Compound 7 (1.10 g, 5 mmol) was dissolved in dichloromethane (DCM) (20 mL) at 0°C under argon protection; then 0.1 mL of catalytic DMF was added, and oxalyl chloride (1.2 mL, 15 mmol) was slowly added via a syringe, and the reaction mixture was stirred at 0°C for 2 hours. The solvent was removed under reduced pressure to obtain the corresponding acyl chloride.

[0094] Under argon protection, 2-amino-5-chloro-N,3-dimethylbenzamide (0.2g, 1.0mmol) and DIPEA (0.2mL, 1.2mmol) were dissolved in anhydrous THF (10mL), and the solution was cooled to 0°C. A solution of the acyl chloride (0.23g, 1.0mmol) prepared in the previous step in anhydrous THF (2mL) was slowly added. The reaction mixture was slowly heated to room temperature and stirred for 12 hours. Then, it was quenched with H2O (8mL), the aqueous phase was extracted with ethyl acetate (3×30mL), the combined organic phases were washed with brine (50mL), dried with anhydrous Na2SO4, and then the solvent was removed under reduced pressure. The residue was subjected to silica gel column chromatography (ethyl acetate / petroleum ether=1:1) to obtain white solid compound 13 (0.25g, 65%). Melting point 189.2-191.0°C. 1 HNMR(500MHz,Chloroform-d)δ10.11(s,1H),7.74(s,1H),7.29(s,2H),6.65(d,J=4.6Hz,1 H), 6.59 (s, 1H), 4.06 (s, 3H), 3.97 (s, 3H), 3.92 (s, 3H), 2.82 (d, J = 4.9Hz, 3H), 2.26 (s, 3H). 13 C NMR (126MHz, CDCl3) δ168.11,164.40,153.55,153.26,143.46,138.46,135.06,132.48,132.1 2,131.82,125.28,114.22,112.43,96.78,57.00,56.51,56.31,26.71,19.12.HRMS(ESI)calcd for C 19 H 22 ClN2O5[M+H] + 393.1212, found 393.1225.

[0095] Example 6

[0096] Preparation of 5-cyano-N,3-dimethyl-2-(2,4,5-trimethoxybenzamido)benzamide (Compound 14):

[0097]

[0098] Referring to the synthesis method of Example 5, compound 7 (0.21 g, 1.0 mmol) and 2-amino-5-cyano-N,3-dimethylbenzamide (0.19 g, 1.0 mmol) were subjected to amidation reaction to synthesize white solid compound 14 (0.26 g, 69% yield). Melting point 172.6-173.4°C. 1 H NMR(500MHz,Chloroform-d)δ10.66–10.33(m,1H),7.72(s,1H),7.65–7.54(m,2H),6.59(s,1 H),6.54–6.33(m,1H),4.08(s,3H),3.97(s,3H),3.91(s,3H),2.93–2.86(m,3H),2.32(s,3H). 13 C NMR (126MHz, CDCl3) δ167.70,163.71,153.67,153.62,143.58,138.79,137.86,135.92,133.72,12 8.77,118.26,114.15,112.08,109.49,96.69,56.97,56.55,56.37,26.90,19.48.HRMS(ESI)calcd for C 20 H 21 N3O5Na[M+Na] + 406.1373, found 406.1386.

[0099] Example 7

[0100] Preparation of 2,4,5-trimethoxy-N-(2-methyl-4-(perfluoropropan-2-yl)phenyl)benzamide (Compound 15):

[0101]

[0102] Referring to the synthesis method of Example 5, compound 7 (0.21 g, 1.0 mmol) was subjected to amidation reaction with 2-methyl-4-(perfluoropropan-2-yl)aniline (0.28 g, 1 mmol) to synthesize white solid compound 15 (0.29 g, 62% yield) with a melting point of 200.4-201.0°C. 1HNMR(500MHz,Chloroform-d)δ10.01(s,1H),8.58(d,J=8.7Hz,1H),7.83(s,1H),7.48(d,J =8.8Hz,1H),7.42(s,1H),6.59(s,1H),4.07(s,3H),3.97(s,3H),3.94(s,3H),2.41(s,3H). 13 C NMR(126MHz, CDCl3)δ163.25,153.21,152.59,143.91,139.93,CF3(127.48,127.40,124.75,124.67),127.04,127.02 ,CF3(122.05,121.83,119.77,119.55),121.37,121.22,121.20,,114.21,113.19,96.65,57.05,56.46,56.37,18.42. 19 F NMR(471MHz, CDCl3)δ-75.73,-75.75,-182.22,-182.24,-182.25,-182.27,-182.28,-182.30,-182.32.HRMS(ESI)calcd for C 20 H 19 F7NO4[M+H] + 470.1197, found 470.1216.

[0103] Example 8

[0104] Preparation of trimethyl((2,4,5-trimethoxybenzyl)oxy)silane (Compound 16):

[0105]

[0106]

[0107] Under argon protection and 0°C, compound 3 (0.2 g, 1 mmol) was added to a solution of DMAP (12.3 mg, 0.1 mmol) and Et3N (0.35 mL, 2.5 mmol) in DCM (5 mL), and TMSCl (0.16 g, 1.5 mmol) was slowly added. The reaction mixture was stirred at 0°C for 1 hour, then heated to room temperature and stirred for another 3 hours. The reaction was quenched with saturated NH4Cl aqueous solution (5 mL), the aqueous layer was extracted with DCM (3×3 mL), the combined organic layers were washed with brine (20 mL), and dried over anhydrous Na2SO4, the solvent was removed under reduced pressure, and the residue was purified by silica gel column chromatography (ethyl acetate / petroleum ether=1:5) to give compound 16 (0.24 g, 90% yield) as a colorless oil with a melting point of 62.0-63.5°C. 1 HNMR(500MHz,Chloroform-d)δ6.99(s,1H),6.50(s,1H),4.67(s,2H),3.88(s,3H),3.85(s,3H),3.80(s,3H),0.15(s,9H). 13 C NMR(126MHz, CDCl3)δ150.72,148.71,143.14,121.02,112.50,97.45,59.50,56.67,56.37,56.34,-0.22.HRMS(ESI)calcd for C 13 H 23 O4Si[M+H] + 271.1366, found 271.1369.

[0108] Example 9

[0109] Preparation of 4-allyl-2-methoxyphenyl 2,4,5-trimethoxybenzoate (Compound 17):

[0110]

[0111] Referring to the synthesis method of Example 2, compound 7 (0.21 g, 1.0 mmol) and 4-allyl-2-methoxyphenol (0.16 g, 1.0 mmol) were subjected to esterification reaction to synthesize white solid compound 17 (0.27 g, 75% yield). Melting point 78.0-78.4°C. 1HNMR(500MHz,Chloroform-d)δ7.63(s,1H),7.06(d,J=7.9Hz,1H),6.83–6.78(m,2H),6.58(s,1H),5.98(ddt,J=16 .8,10.1,6.7Hz,1H),5.16–5.06(m,2H),3.97(s,3H),3.92(s,3H),3.90(s,3H),3.81(s,3H),3.40(d,J=6.7Hz,2H). 13 C NMR (126MHz, CDCl3) δ163.48,156.83,154.28,151.42,142.80,138.81,138.52,137.40,123.07,12 0.83,116.16,115.05,112.93,110.00,98.18,57.46,56.61,56.24,56.07,40.26.HRMS(ESI)calcd forC 20 H 23 O6[M+H] + 359.1489, found 359.1502.

[0112] Example 10

[0113] Preparation of (E)-2-methoxy-4-(prop-1-en-1-yl)phenyl 2,4,5-trimethoxybenzoate (Compound 18):

[0114]

[0115] Referring to the synthesis method of Example 2, compound (7) (0.211 g, 1.0 mmol) and (E)-2-methoxy-4-(prop-1-en-1-yl)phenol (0.16 g, 1.0 mmol) were subjected to esterification reaction to synthesize white solid compound 18 (0.26 g, 73% yield). Melting point 104.2-106.8°C. 1HNMR(500MHz,Chloroform-d)δ7.63(s,1H),7.06(d,J=8.1Hz,1H),6.98–6.90(m,2H),6.58(d,J=2.6Hz,1H),6.44–6.35(m,1 H),6.20(dq,J=15.7,6.6Hz,1H),3.96(s,3H),3.92(d,J=2.8Hz,3H),3.90(s,3H),3.82(s,3H),1.88(dd,J=6.6,1.5Hz,3H). 13 CNMR(126MHz, CDCl3)δ163.37,156.83,154.29,151.52,142.75,139.15,136.88,130.75,125.90, 123.20,118.49,115.01,109.78,98.08,57.39,56.59,56.21,56.01,18.54.HRMS(ESI)calcdforC 20 H 23 O6[M+H] + 359.1489, found 359.1502.

[0116] Embodiment 11

[0117] Preparation of 1-(2,2-dibromovinyl)-2,4,5-trimethoxybenzene (Compound 19):

[0118]

[0119] Under argon protection and 0°C, a solution of PPh3 (2.1 g, 8 mmol) in DCM (4 mL) was added to a solution of CBr4 (1.3 g, 4 mmol) in DCM (4 mL), and the mixture was stirred for 0.5 hours, and then compound 3 (0.4 g, 2 mmol) and Et3N (2.2 mL, 16 mmol) were added in sequence at 0°C. The reaction mixture was stirred at 0°C for 1 hour, then heated to room temperature and stirred for another 8 hours. The reaction was quenched with ice water (5 mL), the aqueous layer was extracted with DCM (3 × 10 mL), the combined organic layers were washed with brine (20 mL), and dried over anhydrous Na2SO4, the solvent was removed under reduced pressure, and the residue was purified by silica gel column chromatography (ethyl acetate / petroleum ether = 1:5) to obtain a colorless oily compound 19 (0.58 g, 83% yield), melting point 63.8-64.8°C. 1H NMR (500MHz, Chloroform-d) δ7.58(s,1H),7.38(s,1H),6.46(s,1H),3.89(s,3H),3.84(s,3H),3.80(s,3H). 13 C NMR(126MHz, CDCl3)δ151.78,150.32,142.52,132.01,115.62,112.21,96.76,87.41,56.63,56.46,56.08.HRMS(ESI)calcd for C 11 H 13 Br2O3[M+H] + 350.9231, found 350.9241.

[0120] Example 12

[0121] Preparation of 1-bromo-2,4,5-trimethoxybenzene (Compound 20):

[0122]

[0123] At 0°C and under argon protection, NBS (0.18 g, 1 mmol) was added to a DCM (5 mL) solution of compound 9 (0.2 g, 1 mmol), and the reaction mixture was stirred at 0°C for 2 hours. The reaction was quenched with ice water (5 mL) and warmed to room temperature. The aqueous layer was extracted with DCM (3×10 mL), and the combined organic layers were washed with brine (20 mL) and dried over anhydrous Na2SO4. The solvent was removed under reduced pressure, and the residue was purified by silica gel column chromatography (ethyl acetate / petroleum ether=1:5) to obtain a colorless oily compound 19 (0.14 g, 56% yield). 1 HNMR(500MHz,Chloroform-d)δ7.02(s,1H),6.55(s,1H),3.87(s,3H),3.85(s,3H),3.82(s,3H). 13 C NMR(126MHz, CDCl3)δ150.43,149.23,143.94,116.60,101.21,99.04,57.34,56.76,56.38.HRMS(ESI)calcd for C9H 12 BrO3[M+H] + 246.9970, found 246.9968.

[0124] Example 13

[0125] 1. Toxicity determination of compounds

[0126] The Laodelphax striatellus was reared in a light incubator in our laboratory (temperature 25±1℃, humidity 70-80%, light 16h / dark 8h). The third-instar Laodelphax striatellus was selected as the test insect for toxicity determination. The toxicity determination was carried out by the drop method, and the instrument was SMARTouch TM Controller for UMP3 (World Precision Instruments LLC, USA); 20 compounds (Compound 1-Compound 20) were dissolved in dimethyl sulfoxide (DMSO) at a concentration of 500 μg / μL; each compound was diluted with acetone into 5 concentration gradients, and 0.05 μL of the agent was dripped on the pronotum of the gray leaf hopper using a drip instrument, and the gray leaf hopper dripped with 0.05 μL acetone was used as a control; each treatment contained 30 gray leaf hoppers, including three biological replicates; the mortality rate was checked 72 hours after treatment, and the results are shown in Table 2.

[0127] Table 2 Toxicity of compounds to 3rd instar Laodelphax striatellus

[0128]

[0129] As shown in Table 2, except for compound 15, compounds 2-8 and designed and synthesized compounds 9-20 all have certain insecticidal effects on Laodelphax striatellus. Compared with compound 1, the insecticidal activity of compounds 7, 8, 9, 10, and 20 on Laodelphax striatellus increased by 4.56-8.31 times, among which compound 10 had the best insecticidal effect on Laodelphax striatellus, increasing by 8.31 times.

[0130] 2. Determination of insecticidal spectrum

[0131] Carrot aphid and peanut aphid were raised in the light incubator of our laboratory, Bemisia tabaci was collected in the greenhouse of our laboratory, and corn aphid and cinnabarinus spider mite were donated by the Institute of Plant Protection, Shandong Academy of Agricultural Sciences. The breeding conditions of the above insects were temperature 25±1℃, humidity 70-80%, light 16h / dark 8h.

[0132] The insects used in the toxicity test were: carrot microtubule aphid, peanut aphid, corn aphid were 3rd instar insects, and Bemisia tabaci and Tetranychus cinnabarinus were adults.

[0133] The toxicity was determined by the drip method, and the instrument was SMARTouch TM Controller for UMP3 (WorldPrecision Instruments LLC, USA).

[0134] Compound 10 was dissolved in dimethyl sulfoxide (DMSO) at a concentration of 500 μg / μL, and the compound was diluted with acetone into 5 concentration gradients. 0.05 μL of the agent was dripped on the back of the test insects using a drip instrument. The test insects dripped with 0.05 μL of acetone were used as controls. Each treatment contained 30 test insects, including three biological replicates. The mortality rate was checked after 72 hours of treatment. The results are shown in Table 3.

[0135] Table 3 Insecticidal spectrum determination of compound 10

[0136]

[0137] As shown in Table 3, compound 10 has excellent insecticidal activity against Hemiptera pests peanut aphid, corn aphid, carrot microtubule aphid, Bemisia tabaci and Tetranychus cinnabarinus of the family Tetranychus, among which compound 10 has the strongest insecticidal activity against Bemisia tabaci and Tetranychus cinnabarinus. Meanwhile, other compounds of the present invention also have similar effects as mentioned above.

Claims

1. An insecticidal compound based on plant-derived β-asarone and a pharmaceutically acceptable salt thereof, characterized in that: The general formula of the insecticide compound is shown in formula (I): Wherein R1 is selected from any of the following: C 1-4 Alkyl, C 1-4 Haloalkyl, C 3-8 Cycloalkyl, C 3-8 Halogenated cycloalkyl, -CH2OH, -CH2OTMS, halogen, -CHO, -COOR2, -CONHR3; The R2 is selected from any one of the following: H, The R3 is selected from any one of the following:

2. The insecticidal compound based on plant-derived β-asarone and its pharmaceutically acceptable salt according to claim 1, characterized in that: The general formula of the insecticide compound is shown in formula (I): Wherein R1 is selected from any one of the following: -CHCHCH3(E), -CHCHCH3(Z), CH2OH, -CH2OTMS, Br, -CHO, -CHCBr2, -COOR2, -CONHR3; The R2 is selected from any one of the following: H, The R3 is selected from any one of the following:

3. An insecticidal compound based on plant-derived β-asarone and a pharmaceutically acceptable salt thereof, characterized in that: The insecticidal compound is selected from any one of the following compounds: 。 4. Use of a compound according to any one of claims 1 to 3 or a pharmaceutically acceptable salt thereof in the preparation of an insecticide or a medicine.

5. The use according to claim 4, characterized in that: Application of the compound or a pharmaceutically acceptable salt thereof in the preparation of insecticides or medicines for field pests.

6. The use according to claim 5, characterized in that: The field pests include Hemiptera pests.

7. The use according to claim 5, characterized in that: The field pests include Laodelphax striatellus, Carrot aphid, Peanut aphid, Corn aphid, Bemisia tabaci and Tetranychus cinnabarinus.

8. An insecticide composition comprising a compound according to any one of claims 1 to 3 or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier or diluent.

9. The pharmaceutical composition according to claim 8, wherein the dosage form of the pharmaceutical composition is preferably selected from emulsifiable concentrates, aqueous emulsions, suspensions or wettable powders.

10. Use of the insecticide composition according to claim 8 in the preparation of insecticide reagents or medicines.